ONALI, PIER LUIGI
 Distribuzione geografica
Continente #
EU - Europa 111.047
NA - Nord America 7.983
AS - Asia 1.031
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 4
SA - Sud America 2
Totale 120.087
Nazione #
IT - Italia 108.487
US - Stati Uniti d'America 7.936
UA - Ucraina 1.094
CN - Cina 724
SE - Svezia 614
DE - Germania 282
FI - Finlandia 246
GB - Regno Unito 190
SG - Singapore 183
IN - India 52
FR - Francia 50
CA - Canada 44
KR - Corea 27
RU - Federazione Russa 19
BE - Belgio 13
NL - Olanda 12
AU - Australia 11
IR - Iran 10
VN - Vietnam 8
CH - Svizzera 7
HK - Hong Kong 7
JP - Giappone 7
TR - Turchia 7
EU - Europa 6
HU - Ungheria 5
PT - Portogallo 5
IE - Irlanda 4
RO - Romania 4
BY - Bielorussia 3
IL - Israele 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
BG - Bulgaria 2
GT - Guatemala 2
LU - Lussemburgo 2
MU - Mauritius 2
BR - Brasile 1
CL - Cile 1
EG - Egitto 1
ES - Italia 1
GE - Georgia 1
GR - Grecia 1
ID - Indonesia 1
IS - Islanda 1
MD - Moldavia 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
SC - Seychelles 1
Totale 120.087
Città #
Cagliari 108.130
Fairfield 1.102
Woodbridge 849
Chandler 684
Jacksonville 606
Wilmington 560
Ashburn 555
Houston 555
Ann Arbor 490
Nyköping 414
Seattle 402
Cambridge 374
Boardman 205
Nanjing 189
Boston 104
Dearborn 91
Helsinki 86
Singapore 84
Beijing 82
San Diego 66
Shenyang 51
Hebei 47
Mountain View 45
Nanchang 43
Shanghai 43
Milan 40
Toronto 40
Los Angeles 39
Changsha 36
Tianjin 35
Redwood City 33
Verona 31
Jiaxing 29
Guangzhou 28
Orange 25
New York 23
Ningbo 22
Norwalk 21
London 19
San Mateo 18
Auburn Hills 15
Indiana 15
Jinan 15
Atlanta 13
Brussels 13
Falls Church 13
Zhengzhou 13
Augusta 12
Taizhou 12
Phoenix 11
Borås 10
Leawood 10
Detroit 9
Hefei 9
Walnut 9
Frankfurt am Main 8
Ardabil 7
Chicago 7
Melbourne 7
Pune 7
Kilburn 6
Kunming 6
Millbury 6
Mumbai 6
Tappahannock 6
Monmouth Junction 5
Munich 5
Sassari 5
Seoul 5
St Louis 5
Vila Nova de Gaia 5
Washington 5
Wuhan 5
Budapest 4
Chiswick 4
Dong Ket 4
Dublin 4
Fuzhou 4
Ho Chi Minh City 4
Montefiascone 4
Philadelphia 4
Rockville 4
Salerno 4
Sarroch 4
Zurich 4
Bangalore 3
Cedar Knolls 3
Central 3
Cluj-Napoca 3
Costa Mesa 3
Edinburgh 3
Fremont 3
Hangzhou 3
Mercato San Severino 3
Minsk 3
Naples 3
Nürnberg 3
Saint Petersburg 3
San Francisco 3
San Giuseppe Jato 3
Totale 116.674
Nome #
Muscarinic acetylcholine receptors potentiate 5'-adenosine monophosphate-activated protein kinase stimulation and glucose uptake triggered by thapsigargin-induced store-operated Ca2+entry in human neuroblastoma cells 3.148
Differential modulation of neurotrophin receptor expression and signaling by Type I Interferons 2.759
Type i interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells 2.607
Type i interferons impair BDNF-induced cell signaling and neurotrophic activity in differentiated human SH-SY5Y neuroblastoma cells and mouse primary cortical neurons 2.458
Agonist activity of N-desmethylclozapine at delta-opioid receptors of human frontal cortex 2.254
Evidence that the GABAB positive allosteric modulator CGP7930 activates MAPK cascade independently of GABAB receptor 2.249
Involvement of store-operated Ca(2+) entry in activation of AMP-activated protein kinase and stimulation of glucose uptake by M3 muscarinic acetylcholine receptors in human neuroblastoma cells. 2.183
Enhancement of human neuroblastoma cell apoptosis by combined treatment with valproic acid and interferonβ 2.172
δ-Opioid receptors stimulate the metabolic sensor AMP-activated protein kinase through coincident signaling with G(q/11)-coupled receptors. 2.166
Protection from interferon-β-induced neuronal apoptosis through stimulation of muscarinic acetylcholine receptors coupled to ERK1/2 activation 2.131
M3 MUSCARINIC ACETYLCHOLINE RECEPTORSACTIVATE THE METABOLIC SENSOR AMP-ACTIVATEDPROTEIN KINASE AND STIMULATE GLUCOSE UPTAKETHROUGH STORE-OPERATED CA2+ ENTRY IN SH-SY5YHUMAN NEUROBLASTOMA CELLS 2.081
Antidepressants activate the lysophosphatidic acid receptor LPA1 to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts 2.072
The atypical antidepressants mianserin and mirtazapine induce ERK1/2 signaling and antiapoptotic effects through activation of the lysophosphatidic acid LPA1 receptor in mouse hippocampal HT22 cells 2.072
Downregulation of TrkB expression and signaling by valproic acid and other histone deacetylase inhibitors 2.058
Involvement of LPA1 lysophosphatidic acid receptor activation in growth factor receptor transactivation by antidepressants 2.052
Interferon-β Inhibits Neurotrophin 3 Signalling and Pro-Survival Activity by Upregulating the Expression of Truncated TrkC-T1 Receptor 2.018
Allosteric modulation of GABA(B) receptor function in human frontal cortex. 1.943
Preclinical and clinical phase I studies of a new recombinant Filgrastim (BK0023) in comparison with Neupogen® 1.860
Interferon-β counter-regulates its own pro-apoptotic action by activating p38 MAPK signalling in human SH-SY5Y neuroblastoma cells 1.835
LPA1 mediates antidepressant-induced ERK1/2 signaling and protection from oxidative stress in glial cells 1.823
LPA1is a key mediator of intracellular signalling and neuroprotection triggered by tetracyclic antidepressants in hippocampal neurons 1.784
Structural and functional characterization of site-specific PEGylated r-met-h-G-CSF 1.697
The GABAB positive allosteric modulators CGP7930 and GS39783 stimulate ERK1/2 signalling in cells lacking functional GABAB receptors 1.650
Inhibition of TNF-α-induced neuronal apoptosis by antidepressants acting through the lysophosphatidic acid receptor LPA1 1.581
null 1.558
Coincidence signaling of dopamine D1-like and M1 muscarinic receptors in the regulation of cyclic AMP formation and CREB phosphorylation in mouse prefrontal cortex 1.538
Potentiation of dopamine D1-like receptor signaling by concomitant activation of δ- And μ-opioid receptors in mouse medial prefrontal cortex 1.500
null 1.498
null 1.341
Signaling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3beta by the recombinant human delta-opioid receptor stably expressed in Chinese hamster ovary cells 1.331
Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes 1.315
null 1.309
The atypical antidepressant mianserin exhibits agonist activity at kappa-opioid receptors 1.308
Enzymatic mono-pegylation of glucagon-like peptide 1 towards long lasting treatment of type 2 diabetes 1.291
Regulation of PI3K/Akt signaling by N-desmethylclozapine through activation of delta-opioid receptor 1.233
null 1.194
null 1.148
Activation of µ- and ð-opioid receptors enhances dopamine D1-like receptor signalling in mouse medial prefrontal cortex. 1.143
Delta-opioid receptors stimulate GLUT1-mediated glucose uptake through Src- and IGF-1 receptor-dependent activation of PI3-kinase signalling in CHO cells 1.135
Interferon-beta induces apoptosis in human SH-SY5Y neuroblastoma cells through activation of JAK-STAT signaling and down-regulation of PIK-Akt pathway 1.110
Antidepressants activate LPA1 lysophosphatidic acid receptor to induce growth factor receptor transactivation 1.016
Activation of nociceptin/orphanin FQ-NOP receptor system inhibits tyrosine hydroxylase phosphorylation, dopamine synthesis, and dopamine D1 receptor signalling in rat nucleus accumbens and dorsal striatum 989
Upregulation of p75NTR by Histone Deacetylase Inhibitors Sensitizes Human Neuroblastoma Cells to Targeted Immunotoxin-Induced Apoptosis 926
null 919
null 882
null 845
null 841
null 817
null 794
Proteinase-activated receptors 1 and 2 in rat olfactory system: layer-specific regulation of multiple signaling pathways in the main olfactory bulb and induction of neurite retraction in olfactory sensory neurons 789
N-desmethylclozapine, a major clozapine metabolite, regulates glycogen synthase 3-β through stimulation of ð opioid receptors and PI3 kìnase/AKt pathway. 776
null 755
RGS proteins 4 and 9 regulate µ-opioid receptor-induced potentiation of dopamine D1-like receptor signaling in mouse medial prefrontal cortex. 726
Evidence of pituitary adenylate cyclase activating polypeptide (PACAP)in pancreatic islet cells by confocal microscopy 704
Stimulation of proteinase-activated receptors 1 and 2 induces neurodegeneration in the rat olfactory system. 698
Stimulation of cyclic AMP formation and nerve electrical activity by octopamine in the terminal abdominal ganglion of the female gypsy moth Limantria dispar 695
Agonist activity of N-Desmethylclozapine, a major clozapine metabolite, at delta opioid receptors. 675
Expression and functional activity of proteinase-activated receptors 1 and 2 in the rat olfactory 656
null 633
N-Desmethylclozapine, a major clozapine metabolite, acts as a selective and effecacious delta-opioid agonist at recombinant and native receptors 617
DUAL COUPLING OF OPIOID RECEPTOR-LIKE (ORL1) RECEPTORS TO ADENYLYL CYCLASE IN THE DIFFERENT LAYERS OF THE RAT MAIN OLFACTORY BULB 597
Destruction of post-synaptic dopamine receptors prevents neuroleptic-induced activation of striatal tyrosine hydroxylase but not dopamine synthesis stimulation. 584
Expression and signalling of protease-activated receptors in distinct layers of rat olfactory bulb and olfactory sensory neurons. 582
Expression of pituitary adenylate cyclase-activating polypeptide (PACAP)receptors and PACAP in human fetal retina 572
Production of interferon-β (INF-β) in E. coli and strategies for improving its bioavailability and pharmacological profile. 571
PEGylation of Recombinant Human Granulocyte Colony-Stimulating Factor (r-h-G-CSF) Produced in Escherichia coli: a New Drug to Overcome Neutropenia 558
Stress induced increase in 3,4 dihydroxyphenylacetic acid (DOPAC)levels in the cerebral cortex and n.accumbens: reversal by diazepam. 548
Expression and signalling mechanism of muscarinic M2 receptor in rat accessory olfacory bulb. 515
Snake toxins that bind to muscarinic acetylcholine receptors 484
Human delta opioid receptors stimulate AMP-activated protein kinase through coincident signaling with Gq/11-coupled receptors 464
Evidence for dopamine receptors in the human brain mediating sedation and sleep 462
Involvement of store-operated Ca2+ entry in AMP-activated protein kinase stimulation by Gq/11-coupled receptors 452
Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors 444
Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors 416
G PROTEIN ACTIVATION AND CYCLIC AMP MODULATION BY NALOXONE BENZOYLHYDRAZONE IN DISTINCT LAYERS OF RAT OLFACTORY BULB 414
Activation of M3 muscarinic acetylcholine receptors protects against interferon-β-induced neuronal cell death. 44th Meeting of the Society for Neuroscience. 15-19 November 2014 Washington, U.S.A. 408
[Phe(1)Phi(CH2-NH)Gly(2)]nociceptin-(1-13)-NH2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells 402
Muscarinic receptors modulate dopamine-activated adenylate cyclase of rat striatum 382
Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists. 381
Inhibition of striatal adenylate cyclase activity by stimulation of muscarinic receptors 378
Interferon-β alters neurotrophin-3 TrkC receptor expression and signaling in differentiated human SH-SY5Y neuroblastoma cells 377
Tricyclic and tetracyclic antidepressants activate LPA1 lysophosphatidic acid receptor signaling in glial cells. 44th Meeting of the Society for Neuroscience. 15-19 November 2014 Washington, U.S.A. 374
Long-term effect of kainic acid on striatal dopaminergic neurons 371
Role of G protein betagamma subunits in muscarinic receptor-induced stimulation and inhibition of adenylyl cyclase activity in rat olfactory bulb 353
Antidepressants induce profibrotic responses via the lysophosphatidic acid receptor LPA1 343
Regulation of AMP-activated protein kinase by human delta opioid receptors 337
The effects of GBL and AP28 on brain dopamine metabolism: a comparative study. 330
Dopamine receptors stimulate high affinity GTPase(s) in rat striatum 329
MUSCARINIC M4 RECEPTOR INHIBITION OF DOPAMINE D1-LIKE RECEPTOR SIGNALLING IN RAT NUCLEUS ACCUMBENS 329
THE PHARMACOLOGICAL ACTION OF MT-7 328
Type I interferons upregulate p75 neurotrophin receptor expression and signaling in human neuroblastoma cells. 325
Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary 324
Sodium ions and GTP decrease the potency of [Nphe1]N/OFQ(1-13) NH2 in blocking nociceptin/orphanin FQ receptors coupled to cyclic AMP in N1E-115 neuroblastoma cells and rat olfactory bulb 323
Stress-induced increase in 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the cerebral cortex and in n. accumbens: reversal by diazepam 322
Dopaminergic modulation of adenylate cyclase stimulated by vasoactive intestinal peptide in male rat anterior pituitary 318
Beta-adrenergic regulation of a Ca++-independent cAMP specific cyclic nucleotide phosphodiesterase in C6 glioma cells. 316
Interferon-β impairs BDNF-induced neuronal signaling and differentiation. 316
Possibile role of insulin in the transport of tyrosine and tryptophan from blood to brain 302
Different DA receptors controlling dopamine synthesis and tyrosine hydroxylase activity 302
BETA/GAMMA-MEDIATED ENHANCEMENT OF CORTICOTROPIN-RELEASING HORMONE-STIMULATED ADENYLYL CYCLASE ACTIVITY BY ACTIVATION OF GAMMA-AMINOBUTYRIC ACID B RECEPTORS IN MEMBRANES OF RAT FRONTAL CORTEX 289
Totale 103.580
Categoria #
all - tutte 160.630
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.630


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022.057 0 0 234 582 9.315 5.532 3.332 833 624 401 523 681
2020/202131.256 977 884 1.113 8.603 7.053 3.120 3.961 1.718 511 1.099 929 1.288
2021/20226.217 912 493 278 506 591 353 240 397 483 527 835 602
2022/202310.353 832 1.111 953 807 642 968 680 1.163 930 783 969 515
2023/202411.838 681 807 503 822 1.167 1.516 1.713 794 470 908 1.305 1.152
2024/202510.718 4.993 5.038 687 0 0 0 0 0 0 0 0 0
Totale 120.318